Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketorolac plus bupivacaine vs bupivacaine alone for hamstring donor site block after ACL reconstruction
TCTR20251224002Phase 3Completed
- Sponsor
- Nutcha Natetaweewat
- Start
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ketorolac, bupivacaine in postoperative pain, sponsored by Nutcha Natetaweewat. Started Apr 2024; status: completed.
02
Drugs
ketorolacbupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on TCTR20251224002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20251224002.